CANBEX THERAPEUTICS LTD has a total of 29 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, United Kingdom and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are AURIMMED PHARMA INC, SSV THERAPEUTICS INC and REVIVA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | United Kingdom | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Norway | 1 | |
#12 | New Zealand | 1 | |
#13 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Selwood David | 22 |
#2 | Baker David | 10 |
#3 | Okuyama Masahiro | 4 |
#4 | Visintin Cristina | 4 |
#5 | Pryce Gareth | 4 |
#6 | David Selwood | 1 |
Publication | Filing date | Title |
---|---|---|
WO2016128771A1 | Compounds for treating disorders associated with bk channel modulation | |
GB201516494D0 | New therapeutic use | |
GB201502415D0 | New therapeutic use | |
GB201502412D0 | Therapeutic use | |
GB201321601D0 | Modulator | |
GB201300903D0 | Crystalline Form |